UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2011
CYCLACEL PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 0-50626 | 91-1707622 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
200 Connell Drive, Suite 1500 Berkeley Heights, NJ | 07922 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:(908) 517-7330
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Votes | Broker Non- | |||||||||||
Votes For | Withheld | Votes | ||||||||||
Spiro Rombotis | 10,677,880 | 465,857 | 23,480,765 | |||||||||
Dr. David U’Prichard | 10,685,474 | 458,263 | 23,480,765 |
Broker Non- | ||||||||||||||||
Votes For | Votes Against | Abstentions | Votes | |||||||||||||
Gregory T. Hradsky | 418,847 | 3,970 | 203,154 | 0 | ||||||||||||
Lloyd Sems | 418,847 | 3,970 | 203,154 | 0 |
Name: Paul McBarron
Title: Executive Vice President—Finance,
Chief Financial Officer and
Chief Operating Officer